RxDoctor Payments Data

Dustin Demoss, DO

Psychiatry · Fort Worth, TXNPI 1730322710

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Brainsway USA Inc accounts for 71.1% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for psychiatry clinicians in TX, where the typical reported total is $228.

$143in general payments, 2019–2025

Across 2 payments — averaging $71.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Brainsway USA Inc$102
  • Indivior Inc.$41
$306,809in research payments, 2019–2025

Across 30 payments — averaging $10,227 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$146K
  • Boehringer Ingelheim$124K
  • Alkermes, Inc.$37K

What the payments were for

  • Food & beverage$143100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Brainsway USA Inc1$102
Indivior Inc.1$41

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$143 in reported general payments places this provider in the 40th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas →

Medicare billing

Part B allowed, 2024
$1,937
Medicare patients
19
Services billed
19

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Fort Worth

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →